ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08955
0,26%
Bitcoin
66.866,04
2,49%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. EQRx Inc (EQRX)

  7. EQRx Inc (EQRX) News

EQRX

EQRx (EQRX)

EQRx Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:EQRX
DatumZeitQuelleÜberschriftSymbolFirma
20/11/202322h00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:EQRXEQRx Inc
20/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:EQRXEQRx Inc
20/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:EQRXEQRx Inc
20/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:EQRXEQRx Inc
09/11/202322h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQRXEQRx Inc
09/11/202322h05Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:EQRXEQRx Inc
09/11/202322h04Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:EQRXEQRx Inc
09/11/202322h03Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:EQRXEQRx Inc
09/11/202322h01Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:EQRXEQRx Inc
09/11/202322h01Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:EQRXEQRx Inc
09/11/202315h29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQRXEQRx Inc
08/11/202317h30GlobeNewswire Inc.Revolution Medicines and EQRx Stockholders Approve EQRx AcquisitionNASDAQ:EQRXEQRx Inc
06/11/202322h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EQRXEQRx Inc
01/11/202313h02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:EQRXEQRx Inc
01/11/202312h59Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EQRXEQRx Inc
01/11/202312h57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQRXEQRx Inc
16/08/202314h07Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EQRXEQRx Inc
08/08/202323h29Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EQRXEQRx Inc
08/08/202323h20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EQRXEQRx Inc
03/08/202322h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQRXEQRx Inc
01/08/202322h38Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EQRXEQRx Inc
01/08/202322h32Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EQRXEQRx Inc
01/08/202322h31Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EQRXEQRx Inc
01/08/202322h29Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EQRXEQRx Inc
01/08/202313h25Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:EQRXEQRx Inc
01/08/202313h19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQRXEQRx Inc
01/08/202313h00GlobeNewswire Inc.Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional CapitalNASDAQ:EQRXEQRx Inc
04/07/202300h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EQRXEQRx Inc
08/05/202323h06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EQRXEQRx Inc
08/05/202322h01GlobeNewswire Inc.EQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial ResultsNASDAQ:EQRXEQRx Inc
 Showing the most relevant articles for your search:NASDAQ:EQRX

Kürzlich von Ihnen besucht

TG
CBK
Commerzbank
TG
DTE
Deutsche Telekom
FX
EURGBP
Euro vs Sterling
DBI
DAX
DAX
COIN
SOLUSD
Solana
AMEX
SPY
SPDR S&P 500
TG
TUI1
Tui
NASDAQ
AMZN
Amazon.com
NASDAQ
TSLA
Tesla
TG
NOV
Novo Nordisk
NYSE
DIS
Walt Disney
PM
XAUUSD
Gold vs US Dollar
COIN
BTCUSD
Bitcoin
NYSE
MCD
McDonalds
NASDAQ
AAPL
Apple
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten